These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32909843)

  • 1. Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems.
    Saint-Raymond A; Sato J; Kishioka Y; Teixeira T; Hasslboeck C; Kweder SL
    Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1095-1101. PubMed ID: 32909843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    Ison MG; Wolfe C; Boucher HW
    JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
    [No Abstract]   [Full Text] [Related]  

  • 3. Remdesivir: First Approval.
    Lamb YN
    Drugs; 2020 Sep; 80(13):1355-1363. PubMed ID: 32870481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.
    Liang C; Tian L; Liu Y; Hui N; Qiao G; Li H; Shi Z; Tang Y; Zhang D; Xie X; Zhao X
    Eur J Med Chem; 2020 Sep; 201():112527. PubMed ID: 32563812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 6. Compassionate Use of Remdesivir for Patients with Severe Covid-19.
    Grein J; Ohmagari N; Shin D; Diaz G; Asperges E; Castagna A; Feldt T; Green G; Green ML; Lescure FX; Nicastri E; Oda R; Yo K; Quiros-Roldan E; Studemeister A; Redinski J; Ahmed S; Bernett J; Chelliah D; Chen D; Chihara S; Cohen SH; Cunningham J; D'Arminio Monforte A; Ismail S; Kato H; Lapadula G; L'Her E; Maeno T; Majumder S; Massari M; Mora-Rillo M; Mutoh Y; Nguyen D; Verweij E; Zoufaly A; Osinusi AO; DeZure A; Zhao Y; Zhong L; Chokkalingam A; Elboudwarej E; Telep L; Timbs L; Henne I; Sellers S; Cao H; Tan SK; Winterbourne L; Desai P; Mera R; Gaggar A; Myers RP; Brainard DM; Childs R; Flanigan T
    N Engl J Med; 2020 Jun; 382(24):2327-2336. PubMed ID: 32275812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missed Opportunities on Emergency Remdesivir Use.
    Sarpatwari A; Kaltenboeck A; Kesselheim AS
    JAMA; 2020 Jul; 324(4):331-332. PubMed ID: 32579163
    [No Abstract]   [Full Text] [Related]  

  • 8. Compassionate Drug Use - Time Arising for a New Law in Bulgaria in the Era of COVID-19.
    Dzhafer N; Papathanasiou JV
    Folia Med (Plovdiv); 2020 Sep; 62(3):592-596. PubMed ID: 33009760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 10. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
    Chua KP; Conti RM
    JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of remdesivir for patients with Covid-19: a review article.
    Azevedo TCP; Azevedo PCP; Silveira Filho RN; Carvalho ARVS; Cezarotti Filho ML; Barbosa FT; Sousa-Rodrigues CF; Matos-Rocha TJ; Ramos FWDS
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):838-841. PubMed ID: 32696862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Remdesivir in the Management of COVID-19: A Systematic Review on Current Evidences.
    Nasir M; Talha KA; Islam T; Saha SK; Selina F; Parveen RA
    Mymensingh Med J; 2020 Apr; 29(2):481-487. PubMed ID: 32506110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid review for the anti-coronavirus effect of remdesivir.
    Li Z; Wang X; Cao D; Sun R; Li C; Li G
    Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compassionate Use of Remdesivir in Covid-19.
    Wu J; Wu B; Lai T
    N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412708
    [No Abstract]   [Full Text] [Related]  

  • 15. Compassionate Use of Remdesivir in Covid-19.
    Hoffmann C
    N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412707
    [No Abstract]   [Full Text] [Related]  

  • 16. Compassionate Use of Remdesivir in Covid-19.
    Fätkenheuer G; Lundgren J
    N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412706
    [No Abstract]   [Full Text] [Related]  

  • 17. Compassionate Use of Remdesivir in Covid-19.
    Bonovas S; Piovani D
    N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412705
    [No Abstract]   [Full Text] [Related]  

  • 18. Compassionate Use of Remdesivir in Covid-19. Reply.
    Grein J; Myers RP; Brainard D
    N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412709
    [No Abstract]   [Full Text] [Related]  

  • 19. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
    Antinori S; Cossu MV; Ridolfo AL; Rech R; Bonazzetti C; Pagani G; Gubertini G; Coen M; Magni C; Castelli A; Borghi B; Colombo R; Giorgi R; Angeli E; Mileto D; Milazzo L; Vimercati S; Pellicciotta M; Corbellino M; Torre A; Rusconi S; Oreni L; Gismondo MR; Giacomelli A; Meroni L; Rizzardini G; Galli M
    Pharmacol Res; 2020 Aug; 158():104899. PubMed ID: 32407959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral treatment for COVID-19: the evidence supporting remdesivir.
    Richardson C; Bhagani S; Pollara G
    Clin Med (Lond); 2020 Nov; 20(6):e215-e217. PubMed ID: 32863273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.